Xcyte Therapies Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
10
Xcyte Therapies General Information
Description
Developer of cancer treatment products. The company develops products to bolster the body's natural immune response to treat cancer, infectious diseases and other medical conditions associated with weakened immune systems.
Contact Information
Website
www.xcytetherapies.comCorporate Office
- 1124 Columbia Street
- Suite 130
- Seattle, WA 98104
- United States
Corporate Office
- 1124 Columbia Street
- Suite 130
- Seattle, WA 98104
- United States
Xcyte Therapies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xcyte Therapies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xcyte Therapies Patents
Xcyte Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003300359-A1 | Generation and isolation of antigen-specific t cells | Inactive | 08-May-2003 | 0000000000 | |
| AU-2003253684-A1 | Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation | Inactive | 28-Jun-2002 | 0000000000 | |
| EP-1401495-A2 | T cell induced tissue repair and regeneration | Inactive | 01-Jun-2001 | 000000000 | 0 |
| AU-2002312308-A1 | T cell induced tissue repair and regeneration | Inactive | 01-Jun-2001 | ||
| EP-1401495-A4 | T cell induced tissue repair and regeneration | Inactive | 01-Jun-2001 | A61K35/12 | 0 |
Xcyte Therapies Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Robert Kirkman MD | Vice President & Chief Business Officer | |
| Peter Langecker Ph.D | Vice President of Clinical Affairs, BioMedicines |
Xcyte Therapies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Xcyte Therapies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xcyte Therapies FAQs
-
When was Xcyte Therapies founded?
Xcyte Therapies was founded in 1996.
-
Who is the founder of Xcyte Therapies?
Ronald Berenson MD is the founder of Xcyte Therapies.
-
Where is Xcyte Therapies headquartered?
Xcyte Therapies is headquartered in Seattle, WA.
-
What is the size of Xcyte Therapies?
Xcyte Therapies has 5 total employees.
-
What industry is Xcyte Therapies in?
Xcyte Therapies’s primary industry is Diagnostic Equipment.
-
Is Xcyte Therapies a private or public company?
Xcyte Therapies is a Private company.
-
What is Xcyte Therapies’s current revenue?
The current revenue for Xcyte Therapies is 000000.
-
How much funding has Xcyte Therapies raised over time?
Xcyte Therapies has raised $122M.
-
Who are Xcyte Therapies’s investors?
ARCH Venture Partners, Alta Partners, CDIB Capital Group, Cercano Management, and Falcon Technology Partners are 5 of 13 investors who have invested in Xcyte Therapies.
-
When was Xcyte Therapies acquired?
Xcyte Therapies was acquired on 15-Dec-2005.
-
Who acquired Xcyte Therapies?
Xcyte Therapies was acquired by Cyclacel Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
